Antibody- and complement-mediated lysis of HIV-infected cells and inhibition of viral replication.
HIV-1-positive antisera were tested for their ability to lyse HIV-1-infected cells in the presence of active complement. Cytolytic effects caused by sera derived from infected humans were slower than those observed with sera from immunised chimpanzees. Lytic but also negative sera were found among HIV-1-infected asymptomatic men as well as among clinical AIDS cases. Human antisera that lysed infected cells reacted similarly irrespective of whether the complement was heterologous or autologous. Analysis of complement-mediated lysis using defined antisera against recombinant HIV-1 env or core antigens suggested that gp160/gp120 and p24 can act as target antigens for an antibody- and complement-mediated cytolysis of infected cells. Complement alone reduced the spread of HIV-1 infection in CD4+ cells and the ability of HIV-1 and HIV-2 to form plaques in CD4-transfected HeLa cells. Co-operative effects of specific antibodies and complement were the most effective in inhibiting HIV infections.
Gregersen
J P
JP
Research Laboratories, Behringwerke AG, Federal Republic of Germany.
Mehdi
S
S
Baur
A
A
Hilfenhaus
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000382:microbiology; D002460:Cell Line; D015941:Complement Hemolytic Activity Assay; D006168:Guinea Pigs; D015497:HIV-1 / Q000276:immunology* / Q000502:physiology; D015498:HIV-2 / Q000276:immunology* / Q000502:physiology; D006304:Health Status; D006801:Humans; D008297:Male; D010948:Viral Plaque Assay; D014779:Virus Replication